|
正常范围促甲状腺激素与心血管疾病的研究进展
|
Abstract:
甲状腺功能与心血管系统之间存在着很大的关联,越来越多的证据表明甲状腺功能亢进、甲状腺功能减退、亚临床甲状腺疾病均与心血管风险增加有关。然而,在甲状腺功能正常的人群中,促甲状腺激素(thyroid stimulating hormone, TSH)与心血管疾病的进展和死亡风险研究较少且存在的争议也较大。现总结近年来正常范围血清TSH的心血管疾病的研究进展,主要从颈动脉粥样硬化、冠心病、高血压、心律失常等方面进行综述。
There is a significant correlation between thyroid function and the cardiovascular system, and increasing evidence suggests that hyperthyroidism, hypothyroidism, and subclinical thyroid diseases are all associated with increased cardiovascular risk. However, in the population with normal thyroid function, there is limited research on the relationship between thyroid stimulating hormone (TSH) and the risk of cardiovascular disease progression and death, and there is also significant controversy. This article summarizes the research progress of cardiovascular diseases with normal serum TSH in recent years, mainly from atherosclerosis of carotid artery, coronary heart disease, hypertension, arrhythmia and other aspects.
[1] | Babić Leko, M., Gunjača, I., Pleić, N. and Zemunik, T. (2021) Environmental Factors Affecting Thyroid-Stimulating Hormone and Thyroid Hormone Levels. International Journal of Molecular Sciences, 22, Article 6521. https://doi.org/10.3390/ijms22126521 |
[2] | Yamada, S., Horiguchi, K., Akuzawa, M., Sakamaki, K., Yamada, E., Ozawa, A., et al. (2023) The Impact of Age-and Sex-Specific Reference Ranges for Serum Thyrotropin and Free Thyroxine on the Diagnosis of Subclinical Thyroid Dysfunction: A Multicenter Study from Japan. Thyroid, 33, 428-439. https://doi.org/10.1089/thy.2022.0567 |
[3] | Wang, X., Li, Y., Zhai, X., Wang, H., Zhang, F., Gao, X., et al. (2021) Reference Intervals for Serum Thyroid-Stimulating Hormone Based on a Recent Nationwide Cross-Sectional Study and Meta-analysis. Frontiers in Endocrinology, 12, Article 660277. https://doi.org/10.3389/fendo.2021.660277 |
[4] | Xu, Y., Derakhshan, A., Hysaj, O., Wildisen, L., Ittermann, T., Pingitore, A., et al. (2023) The Optimal Healthy Ranges of Thyroid Function Defined by the Risk of Cardiovascular Disease and Mortality: Systematic Review and Individual Participant Data Meta-Analysis. The Lancet Diabetes & Endocrinology, 11, 743-754. https://doi.org/10.1016/s2213-8587(23)00227-9 |
[5] | Chen, X., Deng, S., Sena, C., Zhou, C. and Thaker, V.V. (2020) Relationship of TSH Levels with Cardiometabolic Risk Factors in US Youth and Reference Percentiles for Thyroid Function. The Journal of Clinical Endocrinology & Metabolism, 106, e1221-e1230. https://doi.org/10.1210/clinem/dgaa900 |
[6] | 梁辉. 关注颈动脉粥样硬化的规范药物管理[J]. 中华老年心脑血管病杂志, 2020, 22(11): 1121-1123. |
[7] | Can, Y., Ucaroglu Can, N., Kocayigit, I., Kilic, H. and Akdemir, R. (2022) Is Thyroid-Stimulating Hormone a Predictor of Severity of Carotid Artery Disease? European Review for Medical and Pharmacological Sciences, 26, 8311-8316. |
[8] | Sakamaki, K., Tsunekawa, K., Ishiyama, N., Kudo, M., Ando, K., Akuzawa, M., et al. (2021) Association between High Normal-Range Thyrotropin Concentration and Carotid Intima-Media Thickness in Euthyroid Premenopausal, Perimenopausal and Postmenopausal Women. Maturitas, 144, 29-36. https://doi.org/10.1016/j.maturitas.2020.10.022 |
[9] | Gu, Y., Meng, G., Zhang, Q., Liu, L., Wu, H., Zhang, S., et al. (2022) Association of Longitudinal Trends in Thyroid Function with Incident Carotid Atherosclerosis in Middle-Aged and Older Euthyroid Subjects: The Tianjin Chronic Low-Grade Systemic Inflammation and Health (TCLSIH) Cohort Study. Age and Ageing, 51, afab276. https://doi.org/10.1093/ageing/afab276 |
[10] | 孟永霞, 顾叶青, 张庭婧, 等. 甲状腺功能正常人群中基线甲状腺功能与颈动脉粥样硬化关系的队列研究[J]. 中国慢性病预防与控制, 2021, 29(4): 268-272. |
[11] | 巩红, 郑阳, 徐阳, 等. 正常范围内低水平游离甲状腺素与冠脉病变及颈动脉硬化的关系[J]. 西安交通大学学报(医学版), 2018, 39(4): 479-482. |
[12] | 徐阳, 刘晓唤, 巩红, 等. 促甲状腺激素和apoB/apoA与支架内再狭窄的关系[J]. 西安交通大学学报(医学版), 2018, 39(3): 315-318. |
[13] | Sun, L., Xiao, K., Miao, Z., Zhang, Y., Si, J., Shi, N., et al. (2022) Prognostic Value of Normal Thyroid Stimulating Hormone in Long-Term Mortality in Patients with STEMI. Frontiers in Endocrinology, 13, Article 806997. https://doi.org/10.3389/fendo.2022.806997 |
[14] | Ni, W., Kong, S., Lin, K., Huang, Y., Li, J., Shi, S., et al. (2023) Normal Thyroid Stimulating Hormone Is Associated with All-Cause Mortality in Patients with Acute Myocardial Infarction after Percutaneous Coronary Intervention. European Journal of Medical Research, 28, Article No. 199. https://doi.org/10.1186/s40001-023-01149-9 |
[15] | 吴燕, 何敏. 绝经后女性不稳定性心绞痛患者甲状腺激素水平与冠状动脉狭窄程度的相关性分析[J]. 中华老年心脑血管病杂志, 2018, 20(1): 37-41. |
[16] | Marouli, E., Kus, A., Del Greco M, F., Chaker, L., Peeters, R., Teumer, A., et al. (2020) Thyroid Function Affects the Risk of Stroke via Atrial Fibrillation: A Mendelian Randomization Study. The Journal of Clinical Endocrinology & Metabolism, 105, 2634-2641. https://doi.org/10.1210/clinem/dgaa239 |
[17] | 中国高血压防治指南修订委员会, 高血压联盟(中国), 中国医疗保健国际交流促进会高血压病学分会, 等. 中国高血压防治指南(2024年修订版) [J]. 中华高血压杂志(中英文), 2024, 32(7): 603-700. |
[18] | Cai, P., Peng, Y., Chen, Y., Li, L., Chu, W., Wang, Y., et al. (2019) Association of Thyroid Function with White Coat Hypertension and Sustained Hypertension. The Journal of Clinical Hypertension, 21, 674-683. https://doi.org/10.1111/jch.13536 |
[19] | Shin, K.A. and Kim, E.J. (2021) Association between Thyroid Hormone and Components of Metabolic Syndrome in Euthyroid Korean Adults. Medicine, 100, e28409. https://doi.org/10.1097/md.0000000000028409 |
[20] | Verrusio, W., Magro, V.M., Renzi, A., Casciaro, B., Andreozzi, P. and Cacciafesta, M. (2018) Thyroid Hormones, Metabolic Syndrome and Vitamin D in Middle-Aged and Older Euthyroid Subjects: A Preliminary Study. Aging Clinical and Experimental Research, 31, 1337-1341. https://doi.org/10.1007/s40520-018-1071-1 |
[21] | Merchan-Ramirez, E., Sanchez-Delgado, G., Arrizabalaga-Arriazu, C., Acosta, F.M., Arias-Tellez, M.J., Muñoz-Torres, M., et al. (2022) Circulating Concentrations of Free Triiodothyronine Are Associated with Central Adiposity and Cardiometabolic Risk Factors in Young Euthyroid Adults. Journal of Physiology and Biochemistry, 78, 629-640. https://doi.org/10.1007/s13105-022-00881-w |
[22] | Neves, J.S., Fontes-Carvalho, R., Borges-Canha, M., Leite, A.R., von Hafe, M., Vale, C., et al. (2022) Association of Thyroid Function, within the Euthyroid Range, with Cardiovascular Risk: The Epiporto Study. Frontiers in Endocrinology, 13, Article 1067801. https://doi.org/10.3389/fendo.2022.1067801 |
[23] | 孙亚召, 黄捷, 王宁宁, 等. 促甲状腺激素与老年心脑血管病危险因素及患病风险的相关性研究[J]. 临床心血管病杂志, 2023, 39(11): 840-844. |
[24] | Alonso-Ventura, V., Civeira, F., Alvarado-Rosas, A., Lou-Bonafonte, J.M., Calmarza, P., Moreno-Franco, B., et al. (2022) A Cross-Sectional Study Examining the Parametric Thyroid Feedback Quantile Index and Its Relationship with Metabolic and Cardiovascular Diseases. Thyroid, 32, 1488-1499. https://doi.org/10.1089/thy.2022.0025 |
[25] | Alonso-Ventura, V., Campos-Magallon, P., Moreno-Franco, B., Calmarza, P., Calvo-Gracia, F., Lou-Bonafonte, J.M., et al. (2023) An Elevated Parametric Thyroid Feedback Quantile-Based Index Is Associated with Atrial Fibrillation. Frontiers in Endocrinology, 14, Article 1087958. https://doi.org/10.3389/fendo.2023.1087958 |
[26] | Anderson, J.L., Jacobs, V., May, H.T., Bair, T.L., Benowitz, B.A., Lappe, D.L., et al. (2019) Free Thyroxine within the Normal Reference Range Predicts Risk of Atrial Fibrillation. Journal of Cardiovascular Electrophysiology, 31, 18-29. https://doi.org/10.1111/jce.14183 |
[27] | Madhukar, R., Jagadeesh, A.T., Moey, M.Y.Y., Vaglio, M., Badilini, F., Leban, M., et al. (2021) Association of Thyroid-Stimulating Hormone with Corrected QT Interval Variation: A Prospective Cohort Study among Patients with Type 2 Diabetes. Archives of Cardiovascular Diseases, 114, 656-666. https://doi.org/10.1016/j.acvd.2021.06.008 |
[28] | Inoue, K., Ritz, B., Brent, G.A., Ebrahimi, R., Rhee, C.M. and Leung, A.M. (2020) Association of Subclinical Hypothyroidism and Cardiovascular Disease with Mortality. JAMA Network Open, 3, e1920745. https://doi.org/10.1001/jamanetworkopen.2019.20745 |
[29] | Groothof, D., Flores-Guerrero, J.L., Nolte, I.M., Bouma, H.R., Gruppen, E.G., Bano, A., et al. (2020) Thyroid Function and Risk of All-Cause and Cardiovascular Mortality: A Prospective Population-Based Cohort Study. Endocrine, 71, 385-396. https://doi.org/10.1007/s12020-020-02397-z |
[30] | Zhu, P., Lao, G., Chen, C., Luo, L., Gu, J. and Ran, J. (2022) TSH Levels within the Normal Range and Risk of Cardiovascular and All-Cause Mortality among Individuals with Diabetes. Cardiovascular Diabetology, 21, Article No. 254. https://doi.org/10.1186/s12933-022-01698-z |
[31] | de Vries, T.I., de Valk, H.W., van der Graaf, Y., de Borst, G.J., Cramer, M.J.M., Jaap Kappelle, L., et al. (2019) Normal-range Thyroid-Stimulating Hormone Levels and Cardiovascular Events and Mortality in Type 2 Diabetes. Diabetes Research and Clinical Practice, 157, Article 107880. https://doi.org/10.1016/j.diabres.2019.107880. |